What is ICD-10 code C83.08?

C83.08 is the ICD-10-CM diagnosis code for Small cell B-cell lymphoma, lymph nodes of multiple sites. A type of cancer affecting B-cells in multiple lymph node groups throughout the body. It belongs to the ICD-10-CM chapter for neoplasms (c00-d49). C83.08 is a billable code, meaning it can be reported on a claim as a primary or secondary diagnosis when supported by documentation. C83.08 is part of the FY2026 ICD-10-CM code set published by the CMS National Center for Health Statistics and used on Medicare, Medicaid, and commercial claims in the United States.

Yes. C83.08 is a billable ICD-10-CM code that can be reported on professional and institutional claims as a primary or secondary diagnosis when the provider documentation supports the specific condition described. Billable codes in ICD-10-CM are coded to the highest level of specificity available for the documented diagnosis. C83.08 is current for fiscal year 2026 and remains in the active CMS ICD-10-CM code set published by the National Center for Health Statistics.

What is the V28 vs V24 difference for C83.08?

CMS phased in the V28 risk adjustment model over payment years 2024 (33%), 2025 (67%), and 2026 (100%), replacing V24. V28 consolidates HCC categories, removes some lower-acuity conditions, and recalibrates RAF weights across the entire model. For C83.08, V28 maps to Lymphoma and Other Cancers at RAF 0.671 while V24 mapped to Lymphoma and Other Cancers at RAF 0.675. Both models can still appear in legacy data and in payer-specific lookback periods.

What should coders know when reporting C83.08?

Use this code only when lymph nodes in multiple sites are involved; document which specific sites are affected Distinguish from single-site involvement which would use different codes Because C83.08 maps to a payment HCC, the documentation must also satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's risk adjustment score.

2026 ICD-10-CM C83.08: Small cell B-cell lymphoma

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC83.08Effective periodFY2026 Apr Update (Apr 1-Sep 30)

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

C83.08

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Small cell B-cell lymphoma, lymph nodes of multiple sites

A type of cancer affecting B-cells in multiple lymph node groups throughout the body.

Buddy Insight

Small cell B-cell lymphoma involving lymph nodes at multiple sites indicates more advanced disease, typically Stage III or IV.

CMS-HCC V28

Mapped

HCC 21

Lymphoma and Other Cancers

RAF 0.671

CMS-HCC V24

Mapped

HCC 10

Lymphoma and Other Cancers

RAF 0.675

ACA/HHS

Mapped

HCC 10

HHS-HCC 10

Varies by metal level

ESRD/PACE

Mapped

HCC 10

Lymphoma and Other Cancers

RAF 0.111

RXHCC

Mapped

HCC 21

Hodgkin Lymphoma and Other Ca...

RAF 0.410

Code Book Path

Official

C83Non-follicular lymphoma

C83.0Small cell B-cell lymphoma

C83.08Small cell B-cell lymphoma, lymph nodes of multiple sites

Inclusion Terms

Official

Lymphoplasmacytic lymphoma
Nodal marginal zone lymphoma
Non-leukemic variant of B-CLL
Splenic marginal zone lymphoma

Excludes 2

Official

ICD-10-CM does not list Excludes 2 notes for C83.08 in this effective period.

Related Child Codes

Official

C83.00Small cell B-cell lymphoma, unspecified site

C83.01Small cell B-cell lymphoma, lymph nodes of head, face, and neck

C83.02Small cell B-cell lymphoma, intrathoracic lymph nodes

C83.03Small cell B-cell lymphoma, intra-abdominal lymph nodes

C83.04Small cell B-cell lymphoma, lymph nodes of axilla and upper limb

Includes

Official

ICD-10-CM does not list Includes notes for C83.08 in this effective period.

Excludes 1

Official

chronic lymphocytic leukemia (C91.1)
mature T/NK-cell lymphomas (C84.-)
Waldenström macroglobulinemia (C88.00)

Code First

Official

ICD-10-CM does not list Code First sequencing instructions for C83.08 in this effective period.

Use Additional

Official

ICD-10-CM does not list Use Additional Code instructions for C83.08 in this effective period.

Code Also

Official

ICD-10-CM does not list Code Also instructions for C83.08 in this effective period.

Buddy Documentation Tip

HCC Buddy guidance

Pathology-confirmed small cell B-cell lymphoma

Documentation of at least two distinct lymph node regions involved

Specific lymph node groups enumerated in clinical notes or imaging reports

PET/CT or CT staging documenting all sites of involvement

MEAT Support

HCC Buddy guidance

Pathology-confirmed small cell B-cell lymphoma

Documentation of at least two distinct lymph node regions involved

Specific lymph node groups enumerated in clinical notes or imaging reports

PET/CT or CT staging documenting all sites of involvement

Audit Caution

HCC Buddy guidance

Using multiple site code for bilateral involvement of the same region (e.g., bilateral axillary nodes are still one site)

Confusing multiple sites with unspecified site; these have very different meanings

Failing to use C83.08 when documentation clearly describes involvement in two or more distinct node groups

Common Mistakes

HCC Buddy guidance

C83.00 — Unspecified site; use C83.08 when multiple specific sites are documented, not when the site is unknown

C83.09 — Extranodal/solid organ sites; C83.08 is for nodal disease in multiple regions, not organ involvement

Site-specific codes C83.01-C83.06 — Use these when only one specific region is involved; C83.08 requires two or more

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C83.08 an HCC code?

Yes. C83.08 (Small cell B-cell lymphoma, lymph nodes of multiple sites) maps to Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model (and Lymphoma and Other Cancers under V24), with a community non-dual aged RAF of 0.671. It is billable for payment year 2026.

Coder answer: C83.08 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code: C83.08
Description: Small cell B-cell lymphoma, lymph nodes of multiple sites
HCC (V28): HCC 21 — Lymphoma and Other Cancers
RAF: 0.671
Billable: Yes
Payment year: 2026

HCC Category Mapping

V28HCC 21, Lymphoma and Other Cancers

0.671

V24HCC 10, Lymphoma and Other Cancers

0.675

ESRDHCC 10, Lymphoma and Other Cancers

0.111

RxHCCHCC 21, Hodgkin Lymphoma and Other Cancers

0.410

Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

Work C83.08 in the Code Book — tabular path, V28 RAF, and MEAT checklist →

MEAT Criteria for C83.08

For C83.08 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.

MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
EEvaluate: test results, medication response, or physical findings reviewed by the provider
AAssess: explicit mention in the assessment or plan with acknowledgment of status
TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C83.08 during that encounter, not just copy-forwarded from a problem list.

Coder workflow notes

Get the V28 RAF + MEAT cheat sheet

One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C83.08 is the ICD-10-CM diagnosis code for small cell b-cell lymphoma, lymph nodes of multiple sites. A type of cancer affecting B-cells in multiple lymph node groups throughout the body. C83.08 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).

Under the CMS-HCC V28 risk adjustment model, C83.08 maps to Lymphoma and Other Cancers (HCC 21) with a community, non-dual, aged base RAF weight of 0.671. Under the older V24 model, C83.08 mapped to the same category but with a base RAF weight of 0.675, V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

Use this code only when lymph nodes in multiple sites are involved; document which specific sites are affected. Because C83.08 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C83.08 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

•Use this code only when lymph nodes in multiple sites are involved; document which specific sites are affected
•Distinguish from single-site involvement which would use different codes

Clinical Significance

Small cell B-cell lymphoma involving lymph nodes at multiple sites indicates more advanced disease, typically Stage III or IV. Multi-site involvement requires comprehensive staging with PET/CT and has implications for treatment intensity, as it typically indicates systemic rather than localized disease requiring systemic therapy.

Documentation Requirements

✓Pathology-confirmed small cell B-cell lymphoma
✓Documentation of at least two distinct lymph node regions involved
✓Specific lymph node groups enumerated in clinical notes or imaging reports
✓PET/CT or CT staging documenting all sites of involvement
✓Ann Arbor staging reflecting multi-site disease (typically Stage III or IV)

Commonly Confused Codes

•C83.00: Unspecified site; use C83.08 when multiple specific sites are documented, not when the site is unknown
•C83.09: Extranodal/solid organ sites; C83.08 is for nodal disease in multiple regions, not organ involvement
•Site-specific codes C83.01-C83.06: Use these when only one specific region is involved; C83.08 requires two or more